Amphastar P Stock Investor Sentiment

AMPH Stock  USD 45.21  0.99  2.24%   
Under 70 percent of all Amphastar's traders are curious in acquiring. The analysis of overall sentiment of trading Amphastar P stock suggests that a large number of investors are confidant at this time. Amphastar's investing sentiment shows overall attitude of investors towards Amphastar P.

Panic Vs Confidence

70

 
Panic
 
Confidence
Today, several news technology companies offer sentiment data to assist traders in manufacturing news sentiment indicators for investment decisions. We partner with these technology firms in helping retail investors build forecasting models that use Amphastar's input sentiment indicators derived from textual data and news published on major financial information outlets and social sites. These indicators can be used to analyze time-dependent numerical information representing public perception toward Amphastar P.

Amphastar Historical Sentiment

Although Amphastar's investment sentiment alone cannot always predict changes in its future share prices, when combined with other fundamental and technical analysis, a better chance to time the market can be gained. Certain informational and emotional events regarding Amphastar, such as negative comments on social media and news outlets, may cause fear in the market and push Amphastar's investors to sell their holdings. The opposite can also be true when favorable news is released; it may translate into optimism and boost the price of Amphastar.
  

Amphastar Sentiment by Major News Outlets

Investor sentiment, mood or attitude towards Amphastar can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
over three months ago at finance.yahoo.com         
Compared to Estimates, Amphastar Q2 Earnings A Look at Key Metrics
Yahoo News
over three months ago at zacks.com         
Compared to Estimates, Amphastar Q2 Earnings A Look at Key Metrics
zacks News
over three months ago at zacks.com         
Amphastar Pharmaceuticals Tops Q2 Earnings and Revenue Estimates
zacks News
over three months ago at news.google.com         
Public Employees Retirement Association of Colorado Sells 360 Shares of Amphastar Pharmaceuticals, I...
Google News at Macroaxis
over three months ago at finance.yahoo.com         
Amphastar Pharmaceuticals to Release Second Quarter Earnings and Hold Conference Call on August 7, 2...
Yahoo News
over three months ago at finance.yahoo.com         
Disposition of 10282 shares by Peters William J of Amphastar at 20.23 subject to Rule 16b-3
Yahoo News
over three months ago at news.google.com         
Epoch Investment Partners Inc. Purchases 205,932 Shares of Amphastar Pharmaceuticals, Inc. - MarketB...
Google News at Macroaxis
over three months ago at zacks.com         
HCA Healthcare Beats on Q2 Earnings, Ups 2024 EPS View
zacks News
over three months ago at simplywall.st         
Insiders At Amphastar Pharmaceuticals Sold US2.5m In Stock, Alluding To Potential Weakness
Simply Wall St News at Macroaxis
over three months ago at news.google.com         
Amphastar Pharmaceuticals, Inc. Shares Sold by Hillsdale Investment Management Inc. - MarketBeat
Google News at Macroaxis
over three months ago at zacks.com         
UnitedHealth Group Q2 Earnings Beat on Strong Optum Unit
zacks News
over three months ago at finance.yahoo.com         
Why Amphastar is Poised to Beat Earnings Estimates Again
Yahoo News
over three months ago at zacks.com         
Why Amphastar is Poised to Beat Earnings Estimates Again
zacks News
over three months ago at news.google.com         
Amphastar Pharmaceuticals, Inc. Shares Sold by LSV Asset Management - MarketBeat
Google News at Macroaxis
Far too much social signal, news, headlines, and media speculation about Amphastar that are available to investors today. That information is available publicly through Amphastar media outlets and privately through word of mouth or via Amphastar internal channels. However, regardless of the origin, that massive amount of Amphastar data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Amphastar news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Amphastar relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Amphastar's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Amphastar alpha.

Amphastar Performance against Dow Jones

 Price Growth (%)  
       Timeline  
1
Disposition of 3000 shares by Petersen Floyd F. of Amphastar at 46.4724 subject to Rule 16b-3
09/05/2024
2
Disposition of 635 shares by Peters William J of Amphastar at 41.2946 subject to Rule 16b-3
10/11/2024
3
Supernus Pharmaceuticals Beats Q3 Earnings and Revenue Estimates
11/05/2024
4
Amphastar Pharmaceuticals Q3 2024 Earnings EPS of 0.78 Misses Estimates, Revenue at 191. ...
11/06/2024
5
Amphastar Pharmaceuticals Inc Q3 2024 Earnings Call Highlights Resilient Revenue Growth ...
11/07/2024
6
Amphastar Pharmaceuticals, Inc. Q3 2024 Earnings Call Transcript
11/08/2024
7
Disposition of 125000 shares by Zhang Jack Y. of Amphastar subject to Rule 16b-3
11/11/2024
8
Disposition of 2500 shares by Prins Richard K of Amphastar at 16.69 subject to Rule 16b-3
11/12/2024
9
Amphastar Pharmaceuticals executive sells 336,929 in stock
11/14/2024
10
Amphastar Pharmaceuticals to Present at the 36th Annual Piper Sandler Healthcare Conference
11/26/2024

Complementary Tools for Amphastar Stock analysis

When running Amphastar's price analysis, check to measure Amphastar's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Amphastar is operating at the current time. Most of Amphastar's value examination focuses on studying past and present price action to predict the probability of Amphastar's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Amphastar's price. Additionally, you may evaluate how the addition of Amphastar to your portfolios can decrease your overall portfolio volatility.
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm